Asthma
Chronic inflammation and narrowing of the airways.
Begin with your respiratory diagnosis and your pulmonologist’s care plan. Review what is known before considering a product marketed for lung health.

Bring your diagnosis, respiratory history, and current care plan to a conversation with your provider and pulmonary specialist.
Chronic inflammation and narrowing of the airways.
Long-term inflammation of the bronchial tubes, often with a persistent cough.
Chronic obstructive pulmonary disease, a group of conditions that limit airflow.
Damage to the lungs’ air sacs, and one of the main forms of COPD.
Scarring of lung tissue that can make breathing more difficult.
Share lung-function test results, imaging reports, current inhalers, oxygen needs, and any recent hospitalizations. Ask how any proposed option would relate to your ongoing pulmonary care.
What is the exact product and intended use? What evidence supports inhalation for my diagnosis? How would my pulmonologist be involved, and what monitoring would be required?
FDA warns that the regenerative products covered by its consumer alert are not approved for lung diseases such as COPD. No FDA-approved exosome products exist; inhalation does not establish safety or effectiveness.
These educational topics do not confirm treatment availability or establish candidacy. Ask a qualified provider to review the specific proposal.
View patient resources ↓Contact your clinic about consultation availability, fees, and records to provide. Your next step may be further evaluation or a specialist referral.
Find your TNC clinic ↗FDA: Stem cells and exosomes consumer alert ↗
Educational information reviewed October 29, 2026. Discuss your individual circumstances with a qualified provider.